Media Strategy Team

The CoMIT aims to promote human health in society and the activity of the regional economy as a center for developing integrated therapies in immunology and regenerative medicine. The Media Strategy Team contributes to regional bio-campaigns through collaborative activities with regional policymakers, such as the “Osaka Bio Strategy” group in the North Osaka Biocluster, in addition to its general media activities and reports of the center’s activities.

Project Promotion Team

The main function of the CoMIT, which is to conduct integrated research on the immune and regeneration systems in the body, has led to unprecedented and ingenious projects. The Project Promotion Team promotes strategies to obtain research grants for large-scale projects, publicly issued by organizations outside the university, such as the Ministry of Economy, Trade and Industry; the Ministry of Education, Culture, Sports, Science and Technology; and the Ministry of Health, Labour and Welfare. In addition, we collaborate with the New Energy and Industrial Technology Development Organization (NEDO) and the Japan Science and Technology Agency (JST) to promote the projects efficiently.

Regulatory Strategy Team

In order to achieve the center’s goal of human health in society through Life Innovation, proof-of-concept studies of basic research outcomes and commercialization are necessary. To apply basic research to clinical practice and promote its commercialization, it is necessary to address related regulations. The Regulatory Strategy Team plays a crucial role in the regulatory response for each project, in collaboration with the Ministry of Health, Labour and Welfare and the Pharmaceutical and Medical Devices Agency (PMDA).

International Medical Exchange Team

The research outcomes originating from the CoMIT are intended to be utilized internationally, and developed further. The International Medical Exchange Team is involved in the global expansion of research outcomes originating from the center through the collaboration of each project team with overseas research facilities (including academic and industrial facilities). The team engages in overseas technology transfer of research outcomes, and invites foreign scientists, physicians, and entrepreneurs to the center for education and research purposes.

Intellectual Property Strategy Team

Our intellectual property is consolidated based on our research promotion and intellectual property strategies. Osaka University staff and joint research collaborators generally share intellectual property rights based on their collaborative prior agreement. The Intellectual Property Strategy Team efficiently develops intellectual property strategies and promotes patent applications.

Industry-Academia-Government and Interdisciplinary Collaboration Team

Although the center is already conducting interdisciplinary research related to immunology and regenerative medicine, further technologies from different fields may be required to generate novel pharmaceuticals and therapeutic techniques from research outcomes. The function of the Industry-Academia-Government and Interdisciplinary Collaboration Team is strategic matching, including interdisciplinary collaboration between medical and engineering sciences and industry–academia collaboration to obtain optimal technologies for commercialization of our research outcomes.